Madras Diabetes Research Foundation

The Utility of ChatGPT in Diabetic Retinopathy Risk Assessment: A Comparative Study with Clinical Diagnosis

Keerthana Raghu, S Tamilselvi, Chitralekha S Devishamani et al.

2023 · 24 Zit.

Assessing the appropriateness and completeness of ChatGPT-4’s AI-generated responses for queries related to diabetic retinopathy

Brughanya Subramanian, Ramachandran Rajalakshmi, Sobha Sivaprasad et al.

2024 · 11 Zit.

Recent advances in artificial intelligence-assisted endocrinology and diabetes

Ioannis Oikonomakos, Ranjit Mohan Anjana, Viswanathan Mohan et al.

2023 · 6 Zit.

Computational Intelligence in Otorhinolaryngology

Sunil Mathews, Ruchima Dham, Angshuman Dutta et al.

2023 · 3 Zit.

Artificial intelligence and diabetes: time for action and caution

Stefan R Bornstein, Amit Kumar Dey, Charlotte Steenblock et al.

2025 · 3 Zit.

The Utility of ChatGPT in Diabetic Retinopathy Risk Assessment: A Comparative Study with Clinical Diagnosis [Response to Letter]

Keerthana Raghu, S Tamilselvi, Chitralekha S Devishamani et al.

2024 · 2 Zit.

The evolving role of artificial intelligence in optimizing treatment and patient selection in diabetic macular edema

Dhanashree Ratra, Ramachandran Rajalakshmi, M Suchetha et al.

2026 · 0 Zit.

The emerging role of artificial intelligence in ENT surgery

Roopak Vaidhyswaran, Aprajith Sathish Kumar, Geetha T. V. et al.

2026 · 0 Zit.